http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005202086-A1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2002-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d07a8b538a0c50df37b03eb7ad6b923
publicationDate 2005-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2005202086-A1
titleOfInvention Sustained release tablet containing indapamide
abstract The present invention relates to a sustained release tablet containing indapamide and the process of manufacturing sustained release tablet containing indapamide. The tablet contains indapamide in the amount of 1.5 to 2.5% of the total mass of the tablet, lactose monohydrate in the amount of 30 to 80% of the total mass of the tablet, copovidone in the amount of 2 to 10% of the total mass of the tablet, hypromellose in the amount of 20 to 65% of the total mass of the tablet and lubricants in the amount of 0.1 to 5% of the total mass of the tablet. The process of manufacturing the sustained release tablet consists in mixing of indapamide with lactose monohydrate and copovidone and then, the mixture is moistened by purified water and the granulation process of it is performed. Next the granulate is dried, cooled, mixed with hypromellose and lubricants and compressed in tableting machine.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387178-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011263660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105012275-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014079779-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8470363-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112370433-A
priorityDate 2002-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6077534-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6294200-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5334392-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426361
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128685069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406927
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6432616
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829

Total number of triples: 33.